Online citations, reference lists, and bibliographies.
← Back to Search

In Vitro Study Of Polyoxyethylene Alkyl Ether Niosomes For Delivery Of Insulin.

A. Pardakhty, J. Varshosaz, A. Rouholamini
Published 2007 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
In this study, niosomes of polyoxyethylene alkyl ethers (Brij) were prepared for encapsulation of insulin by film hydration method. Without cholesterol, brij 35 and brij 58 did not form niosomes, apparently because of relatively large polar head groups in comparison with their alkyl chains. The size of vesicles depended on the cholesterol content, charge incorporation or hydrophilicity of surfactants. Entrapment of insulin in bilayer structure of niosomes protected it against proteolytic activity of alpha-chymotrypsin, trypsin and pepsin in vitro. The maximum protection activity was seen in brij 92/cholesterol (7:3 molar ratios) in which only 26.3+/-3.98% of entrapped insulin was released during 24h in simulated intestinal fluid (SIF). The kinetic of drug release for most formulations could be best described by Baker and Lonsdale equation indicating diffusion based delivery mechanism. These results indicate that niosomes could be developed as sustained release oral dosage forms for delivery of peptides and proteins such as insulin.
This paper references
10.1016/S0928-0987(99)00014-7
Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens?
S. Murdan (1999)
10.1016/S0378-5173(01)00810-9
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol.
R. Agarwal (2001)
Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Z. Wu (2004)
10.1016/S0378-5173(98)00408-6
Pharmacodynamics of insulin in polyethylene glycol-coated liposomes.
A. Kim (1999)
10.1021/JS980286U
Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes.
P. Arunothayanun (1999)
Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen.
J. Brewer (1998)
Controlled release: mechanisms and release.
R. W. Baker (1974)
10.1016/S0378-5173(02)00024-8
Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs.
E. Hosny (2002)
10.1016/J.JCONREL.2004.03.008
Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
M. Morishita (2004)
10.1023/A:1018990928259
Differential Effects of Anionic, Cationic, Nonionic, and Physiologic Surfactants on the Dissociation, α-Chymotryptic Degradation, and Enteral Absorption of Insulin Hexamers
Z. Shao (2004)
10.1007/s00125-001-0751-z
Self-assembled “nanocubicle” as a carrier for peroral insulin delivery
H. Chung (2001)
Liposome targeting in vivo: Problems and opportunities
G. Poste (1983)
10.1021/JS980235X
Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
K. Iwanaga (1999)
10.1016/0005-2736(68)90056-4
Lipid composition and permeability of liposomes.
J. de Gier (1968)
10.3109/10611869409015907
Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice.
G. Parthasarathi (1994)
10.1002/JPS.2600770516
Effect of lipid composition on insulin-mediated fusion of small unilamellar liposomes: a kinetic study.
J. Y. Lai (1988)
10.1080/713840363
Physicochemical Characterization of Influenza Viral Vaccine Loaded Surfactant Vesicles
S. Chattaraj (2003)
Stabilization of liposomes by freeze-thaw- and lyophilization techniques : problems and opportunities
M. Ausborn (1992)
10.1016/J.VACCINE.2003.08.043
Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy.
V. Ferro (2004)
10.3109/08982109809035528
Controlled Topical Delivery of Cyclosporin-a from Nonionic Liposomal Formulations: Mechanistic Aspects
N. Waranuch (1998)
10.1016/J.IJPHARM.2003.07.015
Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin.
T. Morçöl (2004)
10.1016/0378-5173(94)90228-3
Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85)
Toshimitsu Yoshioka (1994)
10.1016/J.JCONREL.2003.12.017
Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
A. Krauland (2004)
10.1080/drd_10_4_251
Development and Physical Characterization of Sorbitan Monoester Niosomes for Insulin Oral Delivery
J. Varshosaz (2003)
10.1016/S0378-5173(98)00129-X
Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads
P. Sriamornsak (1998)
10.7939/R38G8FS2V
Oral delivery of insulin by polymer-coated liposomes
Majid. Tabbakhian (1998)
10.1016/S0378-5173(99)00167-2
Niosomes as a novel peroral vaccine delivery system.
C. Rentel (1999)
10.1016/J.EJPS.2004.03.015
Development and in vivo evaluation of an oral insulin-PEG delivery system.
P. Calceti (2004)
10.1016/S0939-6411(03)00145-0
Development of acrylic-based copolymers for oral insulin delivery.
Aaron C Foss (2004)
Liposomes : a practical approach
R. New (1990)
10.3109/02652048709021824
Adriamycin-loaded niosomes: drug entrapment, stability and release.
A. Rogerson (1987)
10.1016/S0378-5173(01)00579-8
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
The formation, characterization and stability of non-ionic surfactant vesicles
M. Lawrence (1996)
10.1006/JCIS.1993.1479
Nonionic Surfactant Vesicles: A Study of Vesicle Formation, Characterization, and Stability
H. E. Hofland (1993)
10.3109/03639048909052545
The Entrapment of A Human Insulin-Deae Dextran Complex in Different Compound Liposomes
A. Manosroi (1989)
Ph
李幼升 (1989)
10.1111/j.2042-7158.1985.tb04990.x
The preparation and properties of niosomes—non‐ionic surfactant vesicles
A. Baillie (1985)
10.1128/AAC.33.8.1217
Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model.
N. Weiner (1989)
10.1016/0169-409X(89)90018-5
Penetration and enzymatic barriers to peptide and protein absorption
V. Lee (1989)
Pharmacokinetic study of niosome encapsulated insulin.
G. Khaksa (2000)
10.1016/S0927-7765(03)00080-8
Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol
A. Manosroi (2003)
10.1016/S0378-5173(98)00169-0
Non-ionic surfactant based vesicles (niosomes) in drug delivery
I. Uchegbu (1998)
10.1002/JPS.2600720311
Monolayer studies of insulin-lipid interactions.
D. L. Schwinke (1983)
10.1081/DDC-100100348
Nonionic Surfactant Vesicles (Niosomes) of Cytarabine Hydrochloride for Effective Treatment of Leukemias: Encapsulation, Storage, and In Vitro Release
K. Ruckmani (2000)
10.1016/S0378-5173(01)00740-2
Polymethyacrylate based microparticulates of insulin for oral delivery: preparation and in vitro dissolution stability in the presence of enzyme inhibitors.
V. Agarwal (2001)
10.3109/10837459709022622
In vivo evaluation for rhGM-CSF wound-healing efficacy in topical vehicles.
E. Memiṣoǧlu (1997)
10.1016/0168-3659(92)90016-K
Niosomes for oral delivery of peptide drugs
H. Yoshida (1992)
10.1023/A:1016268027854
Influence of Nonionic Liposomal Composition on Topical Delivery of Peptide Drugs into Pilosebaceous Units: An in Vivo Study Using the Hamster Ear Model
S. Niemiec (2004)
10.1016/J.JCONREL.2004.04.013
Oral delivery of macromolecules using intestinal patches: applications for insulin delivery.
K. Whitehead (2004)
10.1021/JS970124I
Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin.
C. Damgé (1997)
10.1111/j.2042-7158.1997.tb06853.x
Polyhedral Non‐ionic Surfactant Vesicles
I. Uchegbu (1997)
10.1016/0378-5173(92)90348-6
Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation
M. Morishita (1992)
10.1016/b978-0-12-391927-4.10024-6
Intermolecular and surface forces
J. Israelachvili (1985)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin.
J. Brewer (1992)



This paper is referenced by
10.1080/00914037.2017.1332623
Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review
G. Amoabediny (2018)
10.1016/J.JDDST.2017.06.018
Advances on the formulation of proteins using nanotechnologies
Irene Santalices (2017)
10.1134/S0965545X10070035
Complexes of anionic liposomes and a cationic polymer: Composition, structure, and characteristics
Dmitry A. Davydov (2010)
10.1016/j.ijpharm.2012.01.025
Nanoporous multilayer poly(L-glutamic acid)/chitosan microcapsules for drug delivery.
Shifeng Yan (2012)
Obeid, Mohammad A. and Gebril, Ayman M. and Tate, Rothwelle J. and Mullen, Alexander B. and Ferro, Valerie A. (2017) Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles
M. Obeid (2018)
10.1155/2014/816103
Niosomes of Ascorbic Acid and α-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats
J. Varshosaz (2014)
10.2217/nnm.13.155
Nonionic surfactant vesicles for delivery of RNAi therapeutics.
Orapan Paecharoenchai (2013)
Formulation and Characterization of Naproxen Containing Niosomes: A Research
P R Shivhare (2015)
10.1080/08982104.2019.1610435
Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation
Rasha A Khallaf (2019)
PRONIOSOMES, AS A DRUG CARRIER FOR TRANSDERMAL DELIVERY of HYDROCHLOROTHIAZIDE AND LISINOPRIL COMBINATION
Peeyush Vasistha (2013)
10.1080/08982104.2018.1556291
Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation
Mohamed S. El-Ridy (2018)
10.1016/B978-0-323-46143-6.00002-6
Core–shell drug carriers: liposomes, polymersomes, and niosomes
N. Dan (2017)
10.1007/978-3-642-29265-1_10
Nanosized Drug Delivery for Enhancement of Oral Bioavailability
M. Özyazıcı (2012)
10.1248/BPB.34.945
Niosomes: a controlled and novel drug delivery system.
Rampal Rajera (2011)
10.1016/j.ijpharm.2014.10.039
Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
P. Li (2014)
Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles
V. Akbari (2015)
10.4155/TDE.15.47
Why most oral insulin formulations do not reach clinical trials.
M. Lopes (2015)
Proniosomes as Nano-Carrier for Transdermal Delivery of Atenolol Niosomal Gel
El-Assal (2018)
10.1016/j.ijpharm.2017.02.007
Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods.
M. Obeid (2017)
Preparation and Evaluation of Mucoadhesive Opthalmic Niosomes of Acyclovir Using Chitosan and Carbopol
Dr. Raghvendra (2016)
PREPARATION AND CHARACTERIZATION OF PHENYTOIN SODIUM NIOSOMES FOR ENHANCED CLOSURE OF SKIN INJURIES
A. A. M. Ali (2014)
10.1080/03639045.2019.1579827
Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies
Mohamed El-Nabarawi (2019)
10.3109/10717544.2013.873837
Nonionic surfactant-based vesicular system for transdermal drug delivery
S. Ghanbarzadeh (2015)
10.30965/9783846751794_010
In vitro – in vivo
Bernhard J. Dotzler (2011)
10.1007/s10544-009-9328-2
Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil
D. Cosco (2009)
10.1016/j.ijpharm.2007.11.037
Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.
D. Paolino (2008)
10.3109/08982104.2012.700460
Brain delivery of olanzapine by intranasal administration of transfersomal vesicles
H. A. Salama (2012)
10.3109/10717544.2014.945130
Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment
L. Abidin (2016)
10.1080/21691401.2017.1296850
Microniosomes for concurrent doxorubicin and iron oxide nanoparticles loading; preparation, characterization and cytotoxicity studies
Behzad Behnam (2018)
Preparation and characterization of giant niosomes
Maryam Homaei (2016)
10.1002/jps.23252
Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
M. González-Rodríguez (2012)
10.1002/jbm.a.32999
Polysorbate cationic synthetic vesicle for gene delivery.
Y. Huang (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar